Where is Aerogen located?

Aerogen is located in Galway, Ireland .

Who is the current CEO of Aerogen?

John Power is the current CEO of Aerogen.

When was the latest funding round of Aerogen?

Aerogen's latest funding round was on Jun 01, 2022.

Where does Aerogen rank among its competitors?

Aerogen ranks 1 amongst 9 active competitors.

Who are the top competitors of Aerogen?

Aerogen's top competitors are Qnovia, Nebu~Flow and Omega Life Science.

Aerogen - 2025 Company Profile, Team, Funding & Competitors - Tracxn

Q: Is Aerogen an acquired company?

Aerogen got acquired by Nektar on Aug 15, 2005.

Aerogen is an acquired company based in Galway (Ireland), founded in 1997 by John Power. It operates as a Manufacturer of vibrating mesh nebulizers for aerosol drug delivery. Aerogen has raised $18M in funding. The company has 9 active competitors, including 4 funded and 2 that have exited. Its top competitors include companies like Qnovia, Nebu~Flow and Omega Life Science.

Company Details

Manufacturer of vibrating mesh nebulizers for aerosol drug delivery. These devices facilitate respiratory therapy across various ventilation settings, including invasive and non-invasive mechanical ventilation, high-flow, and self-ventilating therapies. The technology is designed for ease of use and effectiveness. Products include single-patient-use devices and handheld units for use in conjunction with other respiratory equipment. The company also provides controllers and accessories.

Website: aerogen.com
Social
Email ID: *****@aerogen.com
Registered Address: na

Key Metrics

Founded Year

1997

Location

Galway, Ireland

Stage

Acquired

Total Funding

$18M in 4 rounds

Latest Funding Round

Grant (prize money), Jun 01, 2022, $94.8K

Investors

InterWest Partners & 11 more

Ranked

1^st among 9 active competitors

Similar Companies

Qnovia & 8 more

Exit Details

Acquired by Nektar (Aug 15, 2005)

Aerogen is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
AEROGEN LTD CIN: 0769.712.618 Belgium, Active	Jul 01, 2021	-	-	-
AEROGEN LIMITED CIN: T19UF9988G Singapore, Deadpooled	Dec 05, 2019	-	-	-
Aerogen Medical Devices India Private Limited CIN: U51909DL2019PTC358844 India, Active	Dec 16, 2019	$927K (as on Mar 31, 2022)	-

Get your free copy of Aerogen's company profile

Aerogen got acquired by Nektar on Aug 15, 2005 at an acquisition amount of $32M. It was facilitated by Aquilo Partners.

Click here to take a look at Aerogen's acquisition in detail

Aerogen has raised a total funding of $18M over 4 rounds. Its first funding round was on Sep 17, 1998. Its latest funding round was a Grant (prize money) round on Jun 01, 2022 for $94.8K. 1 investor participated in its latest round, which include InterWest Partners, J P Morgan, Invesco Mutual Fund and Healthcap.

Aerogen has 12 institutional investors including InterWest Partners, J P Morgan and Invesco Mutual Fund.

Here is the list of recent funding rounds of Aerogen:

Date of funding	Funding Amount	Round Name	Post money valuation	Revenue multiple	Investors
Jun 01, 2022	$94.8K	Grant (prize money)	9930399	9343304	European Union
Jan 01, 2020	$236K	Grant (prize money)	7479681	2584185	European Union
Jan 02, 2019	$11.5M	Post IPO	5607660	8242374	Temasek

Access funding benchmarks and valuations. Sign up today!

View details of Aerogen's funding rounds and investors

The founders of Aerogen is John Power. John Power is the CEO of Aerogen.

Here are the details of Aerogen's key team members:

John Power: Founder & CEO of Aerogen. They serve on the board of 1 company.
Contact Info: 1 email address

View details of Aerogen's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Aerogen include Qnovia, Nebu~Flow and Omega Life Science. Here is the list of Top 10 competitors of Aerogen, ranked by Tracxn score:

Overall Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Aerogen 1997, Galway (Ireland), Acquired	Manufacturer of vibrating mesh nebulizers for aerosol drug delivery	$18M	InterWest Partners, J P Morgan & 10 others	58/100
2nd	Qnovia 2018, Richmond (United States), Series B	Developer of inhaled drug delivery devices to deliver a broad range of pharmaceuticals	$50M	DG Ventures, Evolution VC Partners & 4 others	50/100
3rd	Nebu~Flow 2019, Glasgow (United Kingdom), Series A	Developer of aerosol delivery platform technology	$7.97M	Scottish Enterprise, Ascension & 8 others	28/100
4th	Omega Life Science 2011, Migdal HaEmek (Israel), Funding Raised	Developer of a nebulizer	-	Financiere Saint James	22/100
5th	Nebulok 2016, San Sebastian (Spain), Seed	Manufacturer of medical device for nebulized therapies	-	MassChallenge, EIT Health	21/100
6th	HCmed 2014, Taipei (Taiwan), Public	Developer of inhalation device to treat people suffering from respiratory diseases.	-	-	19/100
7th	LIITA Care 2012, Copenhagen (Denmark), Unfunded	Developer of novel therapies to treat respiratory diseases	-	-	16/100
8th	Afrezza 2009, United States, Unfunded	Developer of an inhaled insulin for type 1 and 2 diabetes	-	-	14/100
9th	Portable Inhale Nebulizer 2020, United States, Deadpooled	Provider of an online store for the purchase of nebulizers	-	-	9/100
10th	Convexity Scientific 2013, Fairfield (United States), Series A	Developer of medical devices for respiratory diseases	$300K	Connecticut Innovations, Stonehenge Capital & 1 others	-